Dublin, Ireland, Thursday 7th of October 2010 -- Pixcelldata, a new Irish software company, announces the beta release of Collibio, Next Generation Software for Digital Pathology.

Users of proprietary digital scanner systems and their images can now collaborate immediately through Collibio.

Pixcelldata’s management team has extensive experience and knowledge of the digital pathology domain. Alan Hanley Pixcelldata’s CEO said “We used our collective knowledge to develop Collibio, as an innovative web application for managing digital pathology data.

Improvements in digital pathology scanners are creating the equivalent of Moore’s Law by significantly increasing digital slide output year on year. Collibio solves the problems associated with managing this exponential growth in digital pathology data.

Our priority was to enhance the user experience by eliminating complexities and by efficiently managing multiple projects in a central location. Collibio’s capability to easily create scoring forms on the fly and to store dynamic information will be of huge benefit to participants in projects processing large quantities of high throughput data.

Collibio’s easy to use software allows simultaneous viewing of many images, which combined with multiple annotations layers per slide, will greatly assist productivity.

Because Collibio is a hosted solution there is no requirement to deploy servers and software locally. We utilize the deployed imager server and storage infrastructure, to significantly reduce costs.

We are really excited about how the cost benefits of our flexible pricing model permits clients to buy what they need, when they need it. So if you are running projects for eight months of the year you only pay for eight months and only for the required number of users!

We believe Collibio’s benefits of reducing costs and increasing productivity will improve return on investment thus making digital pathology affordable for all organizations, large and small.

If organizations would like more information, please contact us as we have an open attitude to digital pathology collaboration and business partnerships.”